D. Ruiz-Montesinos

514 total citations
21 papers, 317 citations indexed

About

D. Ruiz-Montesinos is a scholar working on Rheumatology, Immunology and Surgery. According to data from OpenAlex, D. Ruiz-Montesinos has authored 21 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 8 papers in Immunology and 4 papers in Surgery. Recurrent topics in D. Ruiz-Montesinos's work include Rheumatoid Arthritis Research and Therapies (10 papers), Biosimilars and Bioanalytical Methods (5 papers) and Systemic Lupus Erythematosus Research (4 papers). D. Ruiz-Montesinos is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (10 papers), Biosimilars and Bioanalytical Methods (5 papers) and Systemic Lupus Erythematosus Research (4 papers). D. Ruiz-Montesinos collaborates with scholars based in Spain, United States and Italy. D. Ruiz-Montesinos's co-authors include Juan J. Gómez‐Reino, Eva Pérez‐Pampín, Loreto Carmona, M.Á. Descalzo, Tatiana Cobo‐Ibáñez, Alba Erra, Sara Manrique‐Arija, Victoria Navarro‐Compán, Sara Marsal and Fernando Sánchez‐Alonso and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

D. Ruiz-Montesinos

16 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Ruiz-Montesinos Spain 7 247 77 74 40 35 21 317
B J Radovits Netherlands 6 331 1.3× 83 1.1× 51 0.7× 66 1.6× 42 1.2× 6 371
Laura Brockwell United Kingdom 5 172 0.7× 63 0.8× 71 1.0× 33 0.8× 32 0.9× 5 310
Inês Guimarães da Silveira Brazil 8 207 0.8× 79 1.0× 40 0.5× 30 0.8× 29 0.8× 19 282
Adriana Sánchez-Ortíz Mexico 8 199 0.8× 58 0.8× 72 1.0× 28 0.7× 51 1.5× 12 290
V. Bykerk United States 9 161 0.7× 58 0.8× 28 0.4× 30 0.8× 33 0.9× 19 249
Donna Hart Canada 8 206 0.8× 39 0.5× 37 0.5× 30 0.8× 31 0.9× 11 322
I.M. Markusse Netherlands 9 276 1.1× 88 1.1× 60 0.8× 62 1.6× 115 3.3× 24 354
Jessie Risse France 9 205 0.8× 135 1.8× 37 0.5× 11 0.3× 19 0.5× 25 325
Sheldon Wang United States 7 133 0.5× 31 0.4× 39 0.5× 24 0.6× 28 0.8× 10 277
L.G. Schipper Netherlands 6 315 1.3× 120 1.6× 68 0.9× 75 1.9× 67 1.9× 13 364

Countries citing papers authored by D. Ruiz-Montesinos

Since Specialization
Citations

This map shows the geographic impact of D. Ruiz-Montesinos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Ruiz-Montesinos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Ruiz-Montesinos more than expected).

Fields of papers citing papers by D. Ruiz-Montesinos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Ruiz-Montesinos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Ruiz-Montesinos. The network helps show where D. Ruiz-Montesinos may publish in the future.

Co-authorship network of co-authors of D. Ruiz-Montesinos

This figure shows the co-authorship network connecting the top 25 collaborators of D. Ruiz-Montesinos. A scholar is included among the top collaborators of D. Ruiz-Montesinos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Ruiz-Montesinos. D. Ruiz-Montesinos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vela, Paloma, Sílvia Gómez, Rocío Caño, et al.. (2025). Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registry. Arthritis Research & Therapy. 27(1). 103–103. 2 indexed citations
2.
Hernández‐Cruz, Blanca, Manuel José Moreno Ramos, Juan María Blanco-Madrigal, et al.. (2024). Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry. Annals of the Rheumatic Diseases. 83(9). 1189–1199. 13 indexed citations
3.
4.
Álvaro‐Gracia, José María, Carlos Sánchez‐Piedra, Dante R. Culqui, et al.. (2023). Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study. RMD Open. 9(1). e002936–e002936. 5 indexed citations
5.
6.
Rodriguez-García, S. C., Carlos Sánchez‐Piedra, D. Ruiz-Montesinos, et al.. (2021). POS0610 EPIDEMIOLOGIC PROFILE AND CHANNELING TO TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT OVER THE LAST 5 YEARS: DATA FROM THE SPANISH REGISTER BIOBADASER 3.0. Annals of the Rheumatic Diseases. 80. 542–542. 1 indexed citations
7.
Ruiz-Montesinos, D., et al.. (2020). Trichorhinophalangeal syndrome. Reumatología Clínica (English Edition). 16(6). 499–501.
8.
Ruiz-Montesinos, D., et al.. (2019). Treatment with rituximab in juvenile dermatomyositis: Effect on calcinosis. Reumatología Clínica (English Edition). 16(5). 368–370. 4 indexed citations
9.
Ruiz-Montesinos, D., et al.. (2018). Síndrome tricorinofalángico. Reumatología Clínica. 16(6). 499–501.
10.
Ruiz-Montesinos, D., et al.. (2018). Carpal Tunnel Syndrome Due to a Tophus: Low-field Magnetic Resonance Image. Reumatología Clínica (English Edition). 15(6). e149–e150. 1 indexed citations
11.
Hernández, M.V., Carlos Sánchez‐Piedra, Eduardo Cuende, et al.. (2018). Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry. Rheumatology International. 39(3). 509–515. 28 indexed citations
12.
Sánchez‐Piedra, Carlos, D. Ruiz-Montesinos, Carlos Rodríguez‐Lozano, et al.. (2018). Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER. Arthritis Research & Therapy. 20(1). 227–227. 4 indexed citations
13.
Ruiz-Montesinos, D., et al.. (2017). Síndrome del túnel del carpo por tofo: imagen de resonancia magnética de bajo campo. Reumatología Clínica. 15(6). e149–e150. 1 indexed citations
14.
Labrie, Fernand, David F. Archer, Céline Martel, Mario Vaillancourt, & D. Ruiz-Montesinos. (2017). 015 Combined Data of Intravaginal Prasterone against Vulvovaginal Atrophy of Menopause. The Journal of Sexual Medicine. 14(Supplement_5). e356–e356. 2 indexed citations
15.
Ruiz-Montesinos, D., et al.. (2017). Lipoma arborescens in Pediatric Knee. Nuclear Magnetic Resonance. Reumatología Clínica (English Edition). 13(3). 180–181.
16.
Gratacós, Jordi, et al.. (2016). Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature. Advances in Therapy. 33(12). 2150–2159. 12 indexed citations
17.
Labrie, Fernand, D. Ruiz-Montesinos, David F. Archer, et al.. (2015). Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner. Climacteric. 18(6). 817–825. 11 indexed citations
18.
19.
Navarro-Sarabia, F., D. Ruiz-Montesinos, Victoria Navarro‐Compán, et al.. (2009). DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists. BMC Musculoskeletal Disorders. 10(1). 91–91. 21 indexed citations
20.
Carmona, Loreto, M.Á. Descalzo, Eva Pérez‐Pampín, et al.. (2007). All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists. Annals of the Rheumatic Diseases. 66(7). 880–885. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B J Radovits Breakdown of academic impact, for papers by Laura Brockwell Breakdown of academic impact, for papers by Inês Guimarães da Silveira Breakdown of academic impact, for papers by Adriana Sánchez-Ortíz Breakdown of academic impact, for papers by V. Bykerk Breakdown of academic impact, for papers by Donna Hart Breakdown of academic impact, for papers by I.M. Markusse Breakdown of academic impact, for papers by Jessie Risse Breakdown of academic impact, for papers by Sheldon Wang Breakdown of academic impact, for papers by L.G. Schipper
Rankless by CCL
2026